Results 241 to 250 of about 692,862 (304)

OPTimizing Beta-Blocker Dosage in Women Using the Wearable Cardioverter-Defibrillator (OPT-BB Women): Study design. [PDF]

Heart Rhythm O2
Kutyifa V, Burch AE, Russo A, Beck C, Cuneo A, Bonderman D, Perings C, Duncker D, Winzer EB, Hain A, Assmus B, Erath JW.   +11 more
europepmc   +1 more source

Hybrid Solar Cell/Triboelectric Nanogenerator Based on Stable Two‐Dimensional Covalent Organic Frameworks

Advanced Functional Materials, EarlyView.
This study highlights the integration of stable two‐dimensional covalent organic framework (COF) films as photoactive layers in hybrid nanoenergy devices. The results demonstrate their capacity to generate electricity under both sunny and rainy conditions, showcasing versatility and resilience.
Joab D. Guerrero, Susana Ramos‐Terrón, Salvador R. G. Balestra, José M. Malagón, David Aparicio, Lucia Velasco, Asterios Charisiadis, Dooshaye Moonshiram, Margarita Darder, Pilar Aranda, Bernd Wicklein, Gustavo de Miguel, Javier Pérez‐Carvajal, Eva M. García‐Frutos   +13 more
wiley   +1 more source

Cardiovascular Events and Preoperative Beta-Blocker Use in Non-Cardiac Surgery: A Prospective Holter-Based Analysis. [PDF]

Medicina (Kaunas)
Palcău AC, Șerbanoiu LI, Păduraru LF, Bolocan A, Mușat F, Ion D, Păduraru DN, Socea B, Ilieșiu AM.   +8 more
europepmc   +1 more source

Conformal Metallosaccharide Hybrid Films for Protecting Wood Surfaces From Environmental Damage

Advanced Functional Materials, EarlyView.
Ti‐ribose hybrid films fabricated by molecular layer deposition form a conformal and uniform coating on wood surfaces, which provides water repellence, dimensional stability, and resistance to acidic and alkaline environments, while preserving the natural appearance.
Wenwen Wang, Aranzazu Sierra Fernandez, Gabriele Botta, Evgenii Modin, Iva Šarić Janković, Shidong Ji, Junli Liu, Mato Knez   +7 more
wiley   +1 more source

Nonselective Beta-Blocker Associated With Decreased Mortality in Patients With Gastric Varices. [PDF]

Gastro Hep Adv
Moon RH, Chung J, Chang P, Sahota A.
europepmc   +1 more source

Pharmacogenetic and microRNA mechanisms of beta blocker use on bone. [PDF]

J Bone Miner Res
Lary CW, Atkinson EJ, Spillane J, Nayema Z, Roy TA, Peters R, Scott GT, Chen H, Nagarajan A, Brown A, Motyl KJ, Monroe DG, Khosla S.   +12 more
europepmc   +1 more source

Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry. [PDF]

ESC Heart Fail
Pagnesi M, Riccardi M, Sacco A, Tavecchia G, Viola G, Frea S, Briani M, Bertoldi LF, Bertaina M, Potena L, Valente S, Marini M, De Ferrari GM, D'Ettore N, Cardinale A, Camporotondo R, Rota M, Tavazzi G, Morici N, Pappalardo F, Metra M, Altshock‐2 investigators.   +21 more
europepmc   +1 more source

Utility of Cardiopulmonary Exercise Testing in Assessing Beta-Blocker Efficacy in LQTS: Moving Away From One-Size-Fits-All. [PDF]

J Cardiovasc Electrophysiol
El Assaad I, Heilbronner AK, Zahka K, Hammond B, Patel A, Aziz PF.   +5 more
europepmc   +1 more source

Beta blocker use and breast cancer survival by subtypes: A population-based cohort study. [PDF]

Breast
Scott OW, Tin Tin S, Botteri E.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Beta-Blockers for Hemangiomas

2015
Infantile hemangiomas (IHs) are the most common tumors in infancy. Their typical natural history is characterized by an early rapid growth in the first months of life and by a slow spontaneous involution in the first years of life. Even though spontaneous regression of IHs could suggest therapeutic abstention, systemic treatment is the therapy of ...
C. Gelmetti, R. Cavalli
openaire   +3 more sources